Vietnam Approves Merck’s Gardasil For Females Over Age 10
This article was originally published in PharmAsia News
Executive Summary
Vietnam's Health Ministry cleared Merck to market its Gardasil vaccine in the country for preventing the human papillomavirus responsible for cervical cancer. In approving the three-shot treatment for females over the age of 10, the ministry also advised importers, distributors and those who administer the vaccine to report on their activities semi-annually. Cervical cancer is detected in Vietnam at the rate of two in 10,000 women and has a mortality rate of more than 50 percent. (Click here for more
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.